|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 61 of 255 found articles
| Title: |
Corrigendum to “Phase Ib/II trial evaluating the safety, tolerability and immunological activity of durvalumab (MEDI4736) (anti-PD-L1) plus tremelimumab (anti-CTLA-4) combined with FOLFOX in patients with metastatic colorectal cancer” |
| Author: |
Fumet, Jean-David Isambert, Nicolas Hervieu, Alice Zanetta, Sylvie Guion, Jean-Florian Hennequin, Audrey Rederstorff, Emilie Bertaut, Aurélie Ghiringhelli, Francois |
| Appeared in: |
ESMO open |
| Paging: | Volume 8 () nr. 2 pages p. |
| Year: |
2023 |
| Contents: | |
| Publisher: |
European Society for Medical Oncology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 61 of 255 found articles
| << previous | next >> |